학술논문
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study
Document Type
Article
Author
Source
In: BMC Cancer . (BMC Cancer, December 15, 2014, 14(1))
Subject
Language
English
ISSN
14712407